explore -WSS

explore

author：entertainment 2025-09-06 06:16:36 - browse：5729

An eye emerges from lines of binary codes — health tech coverage from STAT — Adobe

Investors are starting to back startups that offer privacy and security services to bolster health AI products already on the market while they wait for crucial safety and privacy regulations to take shape.

Though health leaders are racing to deploy generative AI products that can automatically transcribe doctor-patient conversations during medical appointments or churn through massive repositories of scientific research, they’re still flummoxed about how to measure their quality. Cybersecurity experts have warned that indiscriminately hooking third-party apps up to health system networks could expose sensitive data to hackers as ransomware attacks surge, and regulators and industry groups are rushing to set standards for responsible AI use.

Several government agencies and industry groups are working on rules and recommendations for avoiding bias and safety hazards within medical AI, but hospitals and startups are still in the dark about what exactly those will require and who’ll eventually be liable for any harm caused. It could be months, or even years, before these overlapping rules from multiple federal agencies are in place, and those rules might still change as the technology evolves.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Covid misinformation case heads to Supreme Court

WSS

MD Anderson's Padmanee Sharma responds to research credit suit

Cybersecurity threat forces Lurie Children's to take systems offline

As AI regulations shape up, health tech startups beg for clarity

The real point of Kenneth Smith’s execution by nitrogen gas

Obamacare plans could cover weight loss drugs

Elevance, SCAN deals highlight health insurer acquisition scrutiny

leisure time

explore

hotspot

Continuity nursing helped my family in our darkest PICU moments

Covid misinformation case heads to Supreme Court

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Alkermes shareholders re

Congress may force more Covid

Alkermes shareholders re

Novo Nordisk to expand supply of Wegovy for U.S. patients

In age of alternative facts, a scholarly course on calling out crap

FDA warns medical device makers about rise in fabricated data

hotspot

Secretariat’s lessons for human medicine

FDA drug safety: Singulair case shows systemic surveillance flaws

Medicare Advantage enrollment hits roughly 33.4 million

A $475,000 price tag for a new cancer drug: crazy or meh?

What we need to know about Arena Bioworks

Vertigo drug brings hope for rare neuron disorder, Niemann

focus

knowledge

hotspot

hotspot